ORBUSNEICH (06929) announces its annual performance, with a shareholder profit of 41.89 million US dollars, representing a 5.49% year-on-year increase.

16:40 12/03/2026

Yeju Medical (06929) released its annual performance for the year ending December 31, 2025. The group achieved a revenue of 180 million US dollars during the period, an increase of 9.97% year-on-year. The company's attributable profit reached 41.899 million US dollars, a year-on-year increase of 5.49%, with a basic earnings per share of 5.09 cents US dollars.

ORBUSNEICH (06929) released its annual performance for the year ending December 31, 2025. The group achieved a revenue of 180 million US dollars, an increase of 9.97% compared to the previous year. The company's attributable profit was 41.899 million US dollars, an increase of 5.49% compared to the previous year. Basic earnings per share were 5.09 US cents. The announcement stated that gross profit increased by 7.0% from 115 million US dollars in the year ending December 31, 2024 to 122 million US dollars in the same period in 2025. The increase was mainly attributed to an increase in sales volume during the year.

HARBOUR CENTRE (00051): Deng Sijing will retire as an independent non-executive director.

WHARF REIC (01997): Chow Tak Hee intends to resign as an independent non-executive director.

DATANG RENEW (01798): Provision for impairment of assets will reduce the net profit attributable to owners of the company by approximately RMB 193 million in 2025.

HARBOUR CENTRE (00051): Deng Sijing will retire as an independent non-executive director.

WHARF REIC (01997): Chow Tak Hee intends to resign as an independent non-executive director.

DATANG RENEW (01798): Provision for impairment of assets will reduce the net profit attributable to owners of the company by approximately RMB 193 million in 2025.